Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Dec. 28 to 30, 2020. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of Dec. 28 to 30, 2020. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
U.K. Is First Country to Approve Oxford-AstraZeneca COVID-19 Vaccine
WEDNESDAY, Dec. 30, 2020 (HealthDay News) — Britain became the first country to give authorization to the COVID-19 vaccine developed by AstraZeneca and the University of Oxford, The New York Times reported Wednesday.
Glycemic Control in Type 1 Diabetes Improved During Lockdown
WEDNESDAY, Dec. 30, 2020 (HealthDay News) — On average, glycemic control improved during lockdown among people living with type 1 diabetes, according to a study published online Dec. 23 in Diabetes Care.
First Known U.S. Case of New Variant of COVID-19 Seen in Colorado
WEDNESDAY, Dec. 30, 2020 (HealthDay News) — The first recorded case of a faster-spreading variant of the new coronavirus has been detected in a 20-year-old man in Colorado, Gov. Jared Polis said Tuesday.
Secondary Bloodstream Infections Tied to Poorer COVID-19 Outcomes
WEDNESDAY, Dec. 30, 2020 (HealthDay News) — Hospitalized adult patients with severe COVID-19 and secondary bloodstream infections are more likely to have worse clinical outcomes, including higher in-hospital mortality, according to a study recently published in Clinical Infectious Diseases.
Gaps Found in Opioid Use Disorder Treatment During Pandemic
WEDNESDAY, Dec. 30, 2020 (HealthDay News) — Patients already receiving opioid use disorder treatment continued to receive care during the early weeks of the COVID-19 pandemic, with some disruption to urine testing, according to a research letter published in the Dec. 15 issue of the Journal of the American Medical Association.
Inequities Seen in Accessing Telemedicine During COVID-19
TUESDAY, Dec. 29, 2020 (HealthDay News) — During the COVID-19 pandemic period, there have been inequities in accessing telemedicine, according to a study published online Dec. 29 in JAMA Network Open.
Another COVID-19 Vaccine Candidate Begins Final Clinical Trials
TUESDAY, Dec. 29, 2020 (HealthDay News) — Vaccine maker Novavax, along with federal health researchers, announced Monday that a phase 3 trial will begin on the safety and effectiveness of another COVID-19 vaccine — the fifth shot to reach this final stage of development.
SARS-CoV-2 Reinfection Risk Drops With Presence of Antibodies
TUESDAY, Dec. 29, 2020 (HealthDay News) — Health care workers with anti-spike or anti-nucleocapsid immunoglobulin G antibodies have a reduced risk for severe acute respiratory syndrome coronavirus 2 reinfection in the following six months, according to a study published online Dec. 23 in the New England Journal of Medicine.
Significant Association ID"d Between Hepatitis C, Overactive Bladder .jpg)
Study Looks at Barriers to Initiation of Rotavirus Vaccine 
~16 Percent of COVID Cases Develop Postacute Sequelae of SARS-CoV-2 
Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood 
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children 
Physical Exams May Not Reliably Diagnose Pediatric Pneumonia .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older 
